Pulmonary Arterial Hypertension Clinical Trials

A listing of Pulmonary Arterial Hypertension medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 64 clinical trials
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension (T3PAH)

The main purpose of this clinical trial is to examine the feasibility and effects of tamoxifen in subjects with pulmonary arterial hypertension (PAH). The study will evaluate how well the drug

connective tissue disease
hypertension
tapse
walk tests
  • 82 views
  • 04 Oct, 2022
  • 1 location
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

or improvement in World Health Organization (WHO) functional class in humans with pulmonary artery hypertension (PAH).

epoprostenol
diuretics
hypertension
  • 3 views
  • 09 Apr, 2023
  • 1 location
Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires

Background A heart catheterization is a diagnostic heart procedure used to measure pressures and take pictures of the blood flow through the heart chambers. Magnetic resonance imaging (MRI) fluoroscopy shows continuous pictures of the heart chambers that doctors can watch while they work. Researchers want to test this procedure with …

right heart catheterization
heart surgery
  • 20 views
  • 03 Apr, 2023
  • 1 location
An Open-label, Multi-national, Multi-center, Single-arm, Uncontrolled, Long-term Extension Study of Orally Administered Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH) Who Received Riociguat in a Bayer Clinical Trial (RIALTO)

To provide riociguat therapy to eligible patients with PAH originating from Bayer-sponsored trials with BAY63-2521/ Riociguat / Adempas® who are currently or recently treated in these trials

pulmonary arterial hypertension
riociguat
adempas
  • 2 views
  • 24 Oct, 2022
  • 1 location
Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects

patients with severe associated pulmonary arterial hypertension (APAH) as part of a congenital heart defect with / without Eisenmenger's Syndrome

congenital heart defects
hypertension
apah
  • 1 views
  • 04 Oct, 2022
  • 1 location
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) (FETO)

The purpose of this research is to gather information on the safety and effectiveness of a new procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO).

pulmonary hypoplasia
diaphragmatic hernia
  • 2 views
  • 07 Oct, 2022
  • 1 location
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

The purpose of this research study is to find out more about the drug treprostinil via inhaler and the mechanisms of why patients with pulmonary arterial hypertension related to Interstitial

Accepts healthy volunteers
  • 0 views
  • 03 Apr, 2023
  • 1 location
Effect of Exercise and Respiratory Therapy on Right Ventricular Function in Severe Pulmonary Hypertension

(cardiac index) during exercise. Within the last decade, new disease-targeted medical therapies have been approved for treatment of pulmonary arterial hypertension (PAH). Sequential and upfront

heart failure
pulmonary arterial pressure
pulmonary arterial hypertension
right heart catheterization
  • 7 views
  • 04 Oct, 2022
  • 1 location
Vascular Function in Health & Disease: Rehabilitation for Hypertension; Exercise and Skeletal Muscle Afferent Feedback

Many control mechanisms exist which successfully match the supply of blood with the metabolic demand of various tissues under wide-ranging conditions. One primary regulator of vasomotion and thus perfusion to the muscle tissue is the host of chemical factors originating from the vascular endothelium and the muscle tissue, which collectively …

heart failure
valsartan
antioxidant
exercise test
arginine
  • 0 views
  • 28 Oct, 2022
  • 1 location
Defining a Noninvasive Signature for Pulmonary Vascular Remodeling in Group 3 PH (PH SOLAR)

). Such a signature may identify Group 3 PH responders to PAH-specific therapies. PAH's unique 129Xe MRI signature has been shown in previous studies. Past studies have lacked a pathologic "ground truth

COPD
lung transplant
sarcoidosis
  • 0 views
  • 23 Oct, 2022
  • 1 location